leadf
logo-loader
viewBuddy Platform Ltd

Buddy Platform launches resource monitoring solution in Canada via SaskTel

The agreement represents the first major inroad for Buddy Ohm in the Canadian market.

CanadaMapleLeaf.jpg
SaskTel will be pairing Buddy’s solution with SaskTel’s 4G network

Buddy Platform Ltd (ASX:BUD) and Canadian telecom company SaskTel have reached an agreement to sell Buddy Ohm through SaskTel’s sales teams across the Canadian province of Saskatchewan.

The company’s shares were last trading 8.5% higher intra-day, at $0.255.

Buddy Ohm is a low cost solution for facility resource monitoring and verification, connecting systems that were never designed to work together, while turning energy savings into a strategic asset.

SaskTel is the leading Information and Communications Technology (ICT) provider in Saskatchewan, with over C$1.2 billion in annual revenue and circa 1.4 million customer connections.

Buddy’s partnership with SaskTel will provide for the expansion of Buddy Ohm sales into major commercial and industrial customers in the region.

Importantly, SaskTel is the second mobile operator to sell Buddy Ohm, and represents the first major inroad for the product in the Canadian market.

With this agreement, SaskTel will identify and facilitate sales of Buddy Ohm into key customers looking to reduce their overall energy spend and reduce their carbon footprint.

By bringing Buddy Ohm to this market, SaskTel will be pairing Buddy’s resource monitoring solution with SaskTel’s 4G network – the largest such network in Saskatchewan.

Last month, Buddy reached an agreement with Digicel, the largest mobile operator in the Caribbean, to sell, distribute and install Buddy Ohm through Digicel’s sales and operations teams.

Quick facts: Buddy Platform Ltd

Price: 0.064 AUD

ASX:BUD
Market: ASX
Market Cap: $166.53 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

MGC Pharma updates on ArtemiC coronavirus study and first-ever THC shipment...

MGC Pharmaceuticals Ltd's (ASX:MXC) Roby Zomer speaks to Proactive's Andrew Scott soon after announcing positive results from a pre-clinical study of ArtemiCTM on rats with no pathological changes or differences between the study groups reported. He also discusses its first-ever shipments of the...

3 hours, 9 minutes ago

2 min read